LFCR
Lifecore Biomedical, Inc.$4.14-0.11 (-2.59%)Prev Close$4.25·MCap$261.5M·P/E—·Vol41.3K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$0.00
●
Active Insiders
0
last 12 mo
LFCR Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 3, 2025 | Lake Ryan David | Chief Financial Officer | Sell | 22,932 | $7.71 | $176.8K | 0 |
| Jul 8, 2025 | Josephs Paul | Chief Executive Officer | Sell | 54,857 | $8.19 | $449.3K | 0 |
| Jul 8, 2025 | Lake Ryan David | Chief Financial Officer | Sell | 32,806 | $8.19 | $268.7K | 0 |
| Jul 8, 2025 | Salus Thomas D. | Chief Legal & Administration | Sell | 11,022 | $8.19 | $90.3K | 0 |
| May 23, 2025 | English Aron R. | 10% Owner | Sell | 1,386,060 | $6.59 | $9.13M3.7% OS | 0 |
| May 20, 2025 | Josephs Paul | Chief Executive Officer | Sell | 21,532 | $6.63 | $142.8K | 0 |
| May 13, 2025 | English Aron R. | 10% Owner | Sell | 12,334 | $7.00 | $86.4K | 0 |
| May 8, 2025 | English Aron R. | 10% Owner | Sell | 51,496 | $7.03 | $362.0K | 0 |
| May 5, 2025 | English Aron R. | 10% Owner | Sell | 41,091 | $7.05 | $289.9K | 0 |
| Jan 8, 2025 | Josephs Paul | Chief Executive Officer | Buy | 17,000 | $5.74 | $97.6K | 559,717 |
| Oct 7, 2024 | Kiper Christopher S | Director | Buy | 1,463,414 | $4.10 | $6.00M3.9% OS | 4,084,268+56% |
| Oct 7, 2024 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 10% Owner | Buy | 292,683 | $4.10 | $1.20M0.8% OS | 2,607,433 |
| Jan 18, 2023 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 10% Owner | Buy | 627,746 | $7.97 | $5.00M1.7% OS | 2,438,180+35% |
| Oct 26, 2022 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 10% Owner | Buy | 250,000 | $8.09 | $2.02M0.7% OS | 2,155,694 |
| Jan 14, 2022 | Schechter Joshua | Buy | 10,000 | $10.39 | $103.9K | 13,398+294% | |
| Jan 14, 2022 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 10% Owner | Buy | 387,400 | $10.41 | $4.03M1.0% OS | 2,008,694 |
| Apr 22, 2021 | Walsh Patrick D | Buy | 10,000 | $11.26 | $112.6K | 40,000+33% | |
| Apr 21, 2021 | Burgess Timothy P | Senior VP of Supply Chain | Buy | 5,045 | $9.99 | $50.4K | 10,145+99% |
| Apr 20, 2021 | Morberg John D | Chief Financial Officer | Buy | 2,000 | $11.05 | $22.1K | 19,400 |
| Apr 19, 2021 | Morberg John D | Chief Financial Officer | Buy | 2,000 | $11.08 | $22.2K | 17,400 |
| Apr 16, 2021 | Morberg John D | Chief Financial Officer | Buy | 2,000 | $10.98 | $22.0K | 15,400 |
| Apr 15, 2021 | Bolles Albert D. | Chief Executive Officer | Buy | 9,000 | $10.61 | $95.5K | 45,152 |
| Apr 15, 2021 | Hall James G | Vice President | Buy | 10,000 | $10.62 | $106.2K | 39,151+34% |
| Apr 15, 2021 | Morberg John D | Chief Financial Officer | Buy | 2,000 | $10.64 | $21.3K | 13,400 |
| Apr 14, 2021 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 10% Owner | Buy | 240,587 | $10.02 | $2.41M0.6% OS | 1,745,542 |
| Apr 13, 2021 | Morberg John D | Chief Financial Officer | Buy | 2,000 | $10.18 | $20.4K | 11,400 |
LFCR Insider Buying Activity
The following table shows recent insider purchases of Lifecore Biomedical, Inc. (LFCR) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 8, 2025 | Josephs Paul | Chief Executive Officer | Buy | 17,000 | $5.74 | $97.6K | 559,717 |
| Oct 7, 2024 | Kiper Christopher S | Director | Buy | 1,463,414 | $4.10 | $6.00M3.9% OS | 4,084,268+56% |
| Oct 7, 2024 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 10% Owner | Buy | 292,683 | $4.10 | $1.20M0.8% OS | 2,607,433 |
| Jan 18, 2023 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 10% Owner | Buy | 627,746 | $7.97 | $5.00M1.7% OS | 2,438,180+35% |
| Oct 26, 2022 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 10% Owner | Buy | 250,000 | $8.09 | $2.02M0.7% OS | 2,155,694 |
| Jan 14, 2022 | Schechter Joshua | Buy | 10,000 | $10.39 | $103.9K | 13,398+294% | |
| Jan 14, 2022 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 10% Owner | Buy | 387,400 | $10.41 | $4.03M1.0% OS | 2,008,694 |
| Apr 22, 2021 | Walsh Patrick D | Buy | 10,000 | $11.26 | $112.6K | 40,000+33% | |
| Apr 21, 2021 | Burgess Timothy P | Senior VP of Supply Chain | Buy | 5,045 | $9.99 | $50.4K | 10,145+99% |
| Apr 20, 2021 | Morberg John D | Chief Financial Officer | Buy | 2,000 | $11.05 | $22.1K | 19,400 |
| Apr 19, 2021 | Morberg John D | Chief Financial Officer | Buy | 2,000 | $11.08 | $22.2K | 17,400 |
| Apr 16, 2021 | Morberg John D | Chief Financial Officer | Buy | 2,000 | $10.98 | $22.0K | 15,400 |
| Apr 15, 2021 | Bolles Albert D. | Chief Executive Officer | Buy | 9,000 | $10.61 | $95.5K | 45,152 |
| Apr 15, 2021 | Hall James G | Vice President | Buy | 10,000 | $10.62 | $106.2K | 39,151+34% |
| Apr 15, 2021 | Morberg John D | Chief Financial Officer | Buy | 2,000 | $10.64 | $21.3K | 13,400 |
| Apr 14, 2021 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 10% Owner | Buy | 240,587 | $10.02 | $2.41M0.6% OS | 1,745,542 |
| Apr 13, 2021 | Morberg John D | Chief Financial Officer | Buy | 2,000 | $10.18 | $20.4K | 11,400 |
LFCR Insider Selling Activity
The following table shows recent insider sales of Lifecore Biomedical, Inc. (LFCR) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 3, 2025 | Lake Ryan David | Chief Financial Officer | Sell | 22,932 | $7.71 | $176.8K | 0 |
| Jul 8, 2025 | Josephs Paul | Chief Executive Officer | Sell | 54,857 | $8.19 | $449.3K | 0 |
| Jul 8, 2025 | Lake Ryan David | Chief Financial Officer | Sell | 32,806 | $8.19 | $268.7K | 0 |
| Jul 8, 2025 | Salus Thomas D. | Chief Legal & Administration | Sell | 11,022 | $8.19 | $90.3K | 0 |
| May 23, 2025 | English Aron R. | 10% Owner | Sell | 1,386,060 | $6.59 | $9.13M3.7% OS | 0 |
| May 20, 2025 | Josephs Paul | Chief Executive Officer | Sell | 21,532 | $6.63 | $142.8K | 0 |
| May 13, 2025 | English Aron R. | 10% Owner | Sell | 12,334 | $7.00 | $86.4K | 0 |
| May 8, 2025 | English Aron R. | 10% Owner | Sell | 51,496 | $7.03 | $362.0K | 0 |
| May 5, 2025 | English Aron R. | 10% Owner | Sell | 41,091 | $7.05 | $289.9K | 0 |
LFCR Insiders
Similar Stocks to LFCR
VTRS
Viatris Inc.
$16.64-0.21%
$19.23B
ELAN
Elanco Animal Health Incorporated
$23.02-0.63%
$11.57B
AMRX
Amneal Pharmaceuticals, Inc.
$16.62-3.48%
$5.57B
INDV
Indivior Pharmaceuticals Inc
$34.10-1.06%
$4.36B
ETON
Eton Pharmaceuticals, Inc.
$54.59-5.26%
$1.61B
ANIP
ANI Pharmaceuticals, Inc.
$71.41+1.43%
$1.60B
HROW
Harrow Health, Inc.
$33.98-0.25%
$1.41B
PCRX
Pacira BioSciences, Inc.
$23.81-3.48%
$1.02B